Department of Health and Human Services. Recombinant DNA Advisory Committee. National Institutes of Health. Minutes of Meeting. June 14, 1999.
D000256:Adenoviridae / Q000235:genetics; D017321:Clinical Trials, Phase I as Topic; D004274:DNA, Recombinant / Q000627:therapeutic use; D015316:Genetic Therapy / Q000331:legislation & jurisprudence / Q000379:methods*; D005822:Genetic Vectors / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans; D009316:National Institutes of Health (U.S.) / Q000331:legislation & jurisprudence; D011640:Public Policy; D019572:Retinal Neoplasms / Q000188:drug therapy; D012175:Retinoblastoma / Q000188:drug therapy; D013797:Thebaine / Q000031:analogs & derivatives*; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence
D004274:DNA, Recombinant; D013797:Thebaine; C050152:NIH 10236